Cerebral embolic protection devices and percutaneous carotid artery stenting

International Journal of Cardiovascular Interventions

Volumn 7, Issue 3, 2005, Pages 117-121

  Gruberg, Luis ^a,b   Beyar, Rafael ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL EMBOLISM; ATHEROSCLEROTIC PLAQUE; BALLOON EMBOLIZATION; BRAIN EMBOLISM; CAROTID ARTERY DISEASE; CAROTID ARTERY OBSTRUCTION; DOPPLER ECHOGRAPHY; HIGH RISK PATIENT; HUMAN; IN-STENT RESTENOSIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROSTHESIS FAILURE; RESTENOSIS; REVIEW; STROKE;

BLOOD VESSEL PROSTHESIS IMPLANTATION; CAROTID ARTERY DISEASES; CAROTID ARTERY, COMMON; ENDARTERECTOMY, CAROTID; EQUIPMENT DESIGN; HUMANS; INTRACRANIAL EMBOLISM; STENTS;

EID: 27144492305     PISSN: 14628848     EISSN: 14711796     Source Type: Journal    
DOI: 10.1080/14628840500280542     Document Type: Review

References (26)

1. Ferguson RD, Ferguson JG. Carotid angioplasty. In search of a worthy alternative to endarterectomy. Arch Neurol. 1996;53:696-8.
2. North American Symptomatic CEA Trial Collaborators. Beneficial effect of CEA in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325:445-53.
3. Yadav SS, Roubin GS, Iyer SS, et al. Application of lessons learned from cardiac interventional techniques to carotid angioplasty. J Am Coll Cardiol. 1995:380A.
4. Barnett HJ, Taylor DW, Eliasziw M, et al. for the North American Symptomatic CEA Trial Collaborators. Benefit of CEA in patients with symptomatic moderate or severe stenosis. N Engl J Med. 1998;339:1415-25.
5. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA. 1995;273:1421-8.
6. European Carotid Surgery Trialists' Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet. 1991;337:1235-43.
7. Wennberg DE, Lucas FL, Birkmeyer JD, Bredenberg CE, Fisher ES. Variation in CEA mortality in the Medicare population: trial hospitals, volume, and patient characteristics. JAMA. 1998;279:1278-81.
8. Brott T, Thalinger K. The practice of CEA in a large metropolitan area. Stroke. 1984;15:950-5.
9. Chassin MR. Appropriate use of CEA. N Engl J Med. 1998;339:1468-71.
10. Randomized trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998;351:1379-87.
11. Mayo Asymptomatic CEA Study Group. Results of a randomized controlled trial of CEA for asymptomatic carotid stenosis. Mayo Clin Proc. 1992;67:513-8.
12. Rothwell PM, Slattery J, Warlow CP. A systematic review of the risks of stroke and death due to endarterectomy for symptomatic carotid stenosis. Stroke. 1996;27:260-5.
13. Rothwell PM, Slattery J, Warlow CP. Clinical and angiographic predictors of stroke and death from CEA: systematic review. BMJ. 1997;315:1571-7.
14. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Transluminal Angioplasty Study (CAVATAS): A randomized trial. Lancet, 357:1729-37.
15. Golledge J, Mitchell A, Greenhalgh RM, Davies AH. Systematic comparison of the early outcome of angioplasty and endarterectomy for symptomatic carotid artery disease. Stroke. 2000;31:1439-43.
16. Telman G, Halabi M, Kouperberg E, et al. Microemboli at the Different Stages of Percutaneous Transluminal Carotid angioplasty and stenting in patients with post CEA restenosis compared to primary stenosis. Int J Angiol. 2004;13:37-41.
17. Wholey MH, Al-Mubarak , Wholey MH. Updated review of the global carotid artery stenting registry. Cathet Cardiovasc Diagn. 2003;60:259-66.
18. Kastrup A, Groschel K, Krapf H, Brehm BR, Dichgans J, Schulz JB. Early outcome of carotid angioplasty and stenting with and without cerebral protection devices. A systematic review of the literature. Stroke. 2003;34:813-9.
19. Zahn R, Mark B, Niedermaier N, et al. Embolic protection devices for carotid artery stenting: better results than stenting without protection? European Heart J. 2004;25:1550-8.
20. Reimers B, Schluter M, Castriota F, et al. Routine use of cerebral protection during carotid artery stenting: results of a multicenter registry of 753 patients. Am J Med. 2004;116:217-22.
21. Cremonesi A, Manetti R, Setacci F, Setacci C, Castriota F. Protected carotid stenting. Clinical advantages and complications of embolic protection devices in 442 consecutive patients. Stroke. 2003;34:1936-43.
22. Yen MH, Lee DS, Kapadia S, et al. Symptomatic patients have similar outcomes compared with asymptomatic patients after carotid artery stenting with emboli protection. Am J Cardiol. 2005;95:297-300.
23. Henry M, Henry I, Polydorou A, et al. Carotid angioplasty and stenting under cerebral protection with the PercuSurge GuardWire System. J Interven Cardiol. 2004;17:233-43.
24. Schmidt A, Diederich K-W, Scheinert S, et al. Effect of two different neuroprotection systems on microembolization during carotid artery stenting. J Am Coll Cardiol. 2004; 44:1966-9.
25. Yadav JS, Wholey MH, Kuntz RE, et al. For the SAPPHIRE Investigators. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004;351:1493-501.
26. Halabi M, Gruberg L, Pitchersky S, et al. Carotid artery stenting in high-surgical risk patients. Cath Cardiovasc Intervent, in press.